Literature DB >> 10968909

Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis.

Y Shoenfeld1, D Harats, J George.   

Abstract

We have made consecutive studies to prove that autoimmune factors can influence the progression of atherosclerosis in inbred and transgenic mice. C57BL/6 as well as LDL-receptor deficient mice were immunized with heat shock protein 65. LDL-RD and apolipoprotein E knockout (apoE KO) mice were immunized with human B-glycoprotein I. ApoE KO mice were immunized with oxidized LDL. In all immunized mice, a sustained humoral response to the provided antigen was elicited evident by high titers of antibodies by ELISA. A primary cellular immune response was also shown by thymidine incorporation studies employing the antigens in vitro. Immunization with hsp-65 and with beta 2-GPI served to enhance the progression atherosclerosis and led to an increase in the infiltration of CD3 in the subendothelial regions of the early plaques. Transfer of hsp-65 and beta 2-GPI reactive lymphocytes to syngenic mice led to enhancement of fatty streak formation. However, immunization with homologous oxLDL in apoE KO mice led to attenuation of lesion progression concomitant with the production of anti-oxLDL antibodies. Thus, autoimmune factors appear to influence early artherosclerosis progression in mice. If proven in humans these antigen specific responses may be harnessed for selective immunomodulation of the atherosclerotic plaque. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968909     DOI: 10.1006/jaut.2000.0393

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

Review 1.  Antiinflammatory and immunomodulatory properties of statins.

Authors:  Ora Shovman; Yair Levy; Boris Gilburd; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Intravenous immunoglobulin and atherosclerosis.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Katsumi Inoue; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  The virus-induced HSPs regulate the apoptosis of operatus APCs that result in autoimmunity, not in homeostasis.

Authors:  Norbert O Temajo; Neville Howard
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 4.  Tolerization against atherosclerosis using heat shock protein 60.

Authors:  Cecilia Wick
Journal:  Cell Stress Chaperones       Date:  2015-11-17       Impact factor: 3.667

5.  Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: potential role in anti-atherosclerotic activity.

Authors:  Hong-zhan Li; Yong-heng Lu; Guang-sheng Huang; Qi Chen; Qiang Fu; Zhi-liang Li
Journal:  Chin J Integr Med       Date:  2012-09-21       Impact factor: 1.978

Review 6.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

7.  A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.

Authors:  Pál Soltész; Henriett Dér; György Kerekes; Péter Szodoray; Gabriella Szücs; Katalin Dankó; Yehuda Shoenfeld; Gyula Szegedi; Zoltán Szekanecz
Journal:  Clin Rheumatol       Date:  2009-02-18       Impact factor: 2.980

8.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

9.  Humoral response against small heat shock proteins in Parkinson's disease.

Authors:  Ewa Papuć; Ewa Kurys-Denis; Witold Krupski; Konrad Rejdak
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

10.  Heat-shock proteins in autoimmunity.

Authors:  Kamal D Moudgil; Stephen J Thompson; Fabiana Geraci; Boel De Paepe; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2013-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.